Amprius Raised 2026 Revenue to $130M-But the 25% After-Hours Drop Says the Market Wants More Than a Beat

Q1 revenue beat and guidance raise did not rebuild market trust

Amprius delivered better operating numbers, but the market's reaction suggested investors want more than another quarter of progress. The business is scaling, yet the stock move says confidence still depends on proof that demand can grow without blurring the path to profitability.

What improved in Q1

Amprius posted Q1 revenue of $28.5 million, narrowed the net loss to $5.0 million from $9.4 million, and lifted its 2026 revenue outlook to at least $130.0 million. The company also reiterated targets for net loss below $8.0 million and positive non-GAAP adjusted EBITDA of at least $4.0 million. Those figures are enough to keep the bull case alive.

Why the stock still sold off

Investors did not fully embrace that framing. AMPX fell about 24.72% in after-hours trading after the report. The revenue beat came alongside gross margin pressure from legacy product phase-outs and facility costs. So the negative reaction was less about weak operating trends and more about the market wanting clearer evidence that growth and profitability can improve together.

Defense and mobility demand are now the setup; margins are the test

The guidance raise matters because it shifts the debate from whether demand exists to whether that demand can convert into recognized revenue fast enough to support the new outlook. Amprius is pointing to approximately $500 million in new U.S. defense orders plus a $21.0 million purchase order from a light electric vehicle customer in China. For a small battery supplier, that meaningfully expands the near-term opportunity.

Gross margin is the clearest read-through

In Q1, Amprius reported GAAP gross margin of 20%, or 22% excluding $0.5 million of non-recurring Colorado expenses. That distinction matters because gross margin is one of the first signals that rising demand is matching stronger product economics. If higher-value products are truly mixing in, gross profit should improve as the ramp continues. If not, the market will remain cautious about how much weight to give the guidance raise.

What needs to convert next

The next test is straightforward: order conversion, cleaner manufacturing, and better margin performance. Defense and drone programs can take time to qualify, but they can also produce more durable revenue once they do. Mobility can help too, particularly if contract manufacturing allows Amprius to scale without taking on disproportionate fixed cost risk. The key proof point, though, remains margins.

Q2 offered a sharper check. Amprius reported second-quarter 2026 revenue of $34.0 million, and gross profit improved to $9.3 million. Cash and cash equivalents were $74.5 million, total liabilities fell to $23.5 million, and operating cash flow was -$2.9 million. That gives the company room to keep ramping, even if it does not settle the full profitability question.

Institutional support is visible, but insider selling still limits the signal

The ownership picture suggests growing institutional attention, but that is not the same as a definitive conviction signal.

What the ownership data shows

Amprius has 49.38% institutional ownership, with Vanguard owning 5.21% and BlackRock at about 7.40%. That matters for liquidity and market confidence. It also suggests institutional investors are willing to support the stock while execution continues.

Why insider activity still matters

Over the last six months, Amprius insiders logged 0 purchases and 22 sales. That does not invalidate the operating story, but in a volatile name, it does weaken the alignment signal. Institutional ownership can help sustain interest; it cannot replace management putting fresh capital behind the same narrative it is asking investors to fund.

What would make the raised outlook more credible

The case for Amprius now rests on a short list of execution markers:

• revenue growth that continues to outperform expectations
• gross profit that improves as mix and manufacturing stabilize
• a stronger cash position and lower liabilities
• evidence that program qualification and customer conversion are moving forward
• insider buying that reinforces management's confidence

Until that checklist fills, the market is likely to keep treating Amprius as a promising ramp story rather than a fully proven turnaround.